.gif){kind=logo}
Monday, July 21- Theravance, Inc. (NASDAQ: THRX)'s PDUFA date for Telavancin for the treatment of complicated skin infections.
- Merck & Co., Inc. (NYSE: MRK) to report Q2 earnings; conference call at 9:00am.
- Bank of America Corporation (NYSE: BAC) to report Q2 earnings; conference call at 9:30am.
- Apple, Inc. (NASDAQ: AAPL) to report Q3 earnings; conference call at 5:00pm.
- Texas Instruments Incorporated (NYSE: TXN) to report Q2 earnings; conference call at 5:30pm.
- United Parcel Services, Inc. (NYSE: UPS) to report Q3 earnings; conference call at 8:30am.
- Halliburton Company (NYSE: HAL) to report Q2 earnings; conference call at 9:00am.
- Caterpillar Inc. (NYSE: CAT) to report Q2 earnings; conference call at 11:00am.
- Lockheed Martin Corporation (NYSE: LMT) to report Q2 earnings; conference call at 11:00am.
- Yahoo!, Inc. (NASDAQ: YHOO) to report Q2 earnings; conference call at 5:00pm.
Wednesday, July 23
- Amgen, Inc. (NASDAQ: AMGN)'s PDUFA date rescheduled from 4/23. Management's submission to FDA of robust risk management plan after FDA ODAC panel meeting was considered by FDA as major amendment to Nplate's BLA causing 3-month review extension according to current PDUFA rules.
- AT&T, Inc. (NYSE: T) to report Q2 earnings; conference call at 10:00am.
- The Boeing Company (NYSE: BA) to report Q2 earnings; conference call at 10:30am.
- PepsiCo, Inc. (NYSE: PEP) to report Q2 earnings; conference call at 11:00am.
- McDonald's Corporation (NYSE: MCD) to report Q2 earnings; conference call at 1:00pm.
- Amazon.com, Inc. (NASDAQ: AMZN) to report Q2 earnings; conference call at 5:00pm.
- The Dow Chemical Company (NYSE: DOW) to report Q2 earnings; conference call at 10:00am.
- Southwest Airlines Co. (NYSE: LUV) to report Q2 earnings; conference call at 12:30pm.
- CV Therapeutics, Inc. (NASDAQ: CVTX)'s PDUFA date for supplemental New Drug Application, sNDA and New Drug Application, NDA, for Ranolazine (Ranexa).
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA)'s and Titan Pharmaceuticals (AMEX: TTP)'s PDUFA date for Fanapta (Iloperidone), a serotonin/dopamine receptor blocking agent for treating Schizophrenia.
- Eisai Co., Ltd. (OTC: ESALY) and MGI Pharma's PDUFA date for Aquavan injection (Fospropofol Disodium Injection), a sedative-hypnotic agent in patients undergoing diagnostic or therapeutic procedure.
- Schering-Plough Corporation (NYSE: SGP)'s PDUFA date for Organon Asenapine for the treatment of schizophrenia.
Is the market always right?
Comfort Zone Investing: How this all might play out
Stock picks and pans for troubled times: AAPL, COST, EWBC, IBM, YUM, PG ...
Add your comments